Anti-nociceptive effect of kinin B 1 and B 2 receptor antagonists on peripheral neuropathy induced by paclitaxel in mice

British Journal of Pharmacology

Volumn 164, Issue 2 B, 2011, Pages 681-693

  Costa, Robson ^a   Motta, Emerson M ^a   Dutra, Rafael C ^a   Manjavachi, Marianne N ^a   Bento, Allisson F ^a   Malinsky, Fernanda R ^b   Pesquero, João B ^b   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

B 1 receptor; B 2 receptor; chemotherapy; kinin; neuropathic pain; paclitaxel

Indexed keywords

ANTINOCICEPTIVE AGENT; DALBK; DES 9 ARGINYL 8 LEUCYLBRADYKININ; ICATIBANT; KININ; KININ B1 RECEPTOR; KININ B2 RECEPTOR; KININ B2 RECEPTOR ANTAGONIST; KININ B3 RECEPTOR ANTAGONIST; KININ DERIVATIVE; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HINDLIMB; HYPERALGESIA; KNOCKOUT MOUSE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WILD TYPE;

ANALGESICS; ANIMALS; BRADYKININ; HYPERALGESIA; KININS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RNA, MESSENGER;

EID: 80052243161     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01408.x     Document Type: Article

References (58)

1. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1): S1-S254.
2. 2 receptors. Hypertension 29: 483-487. (Pubitemid 27074087)
3. 2 receptor null mutant mice. Hypertension 33: 1436-1440. (Pubitemid 29282667)
4. Beggs S, Liu XJ, Kwan C, Salter MW, (2010). Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier. Mol Pain 6: 74.
5. Begley DJ, Brightman MW, (2003). Structural and functional aspects of the blood-brain barrier. Prog Drug Res 61: 39-78. (Pubitemid 37187402)
6. Bujalska M, Makulska-Nowak H, (2009a). Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine- and streptozotocin-induced hyperalgesia. Pharmacol Rep 61: 631-640.
7. Bujalska M, Makulska-Nowak H, (2009b). Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model. Neuro Endocrinol Lett 30: 144-152.
8. Bujalska M, Tatarkiewicz J, Gumułka SW, (2008). Effect of bradykinin receptor antagonists on vincristine- and streptozotocin-induced hyperalgesia in a rat model of chemotherapy-induced and diabetic neuropathy. Pharmacology 81: 158-163. (Pubitemid 351182691)
9. Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM, (2004). Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 143: 803-818. (Pubitemid 39664839)
10. Campana WM, Eskeland N, Calcutt NA, Misasi R, Myers RR, O'Brien JS, (1998). Prosaptide prevents paclitaxel neurotoxicity. Neurotoxicology 19: 237-244. (Pubitemid 28150974)
11. 1 receptors: new insights into their therapeutic potential for the management of inflammation and pain. Trends Pharmacol Sci 27: 646-651. (Pubitemid 44738091)
12. Capuano A, De Corato A, Lisi L, Tringali G, Navarra P, Dello Russo C, (2009). Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain 5: 43.
13. Cavaletti G, Tredici G, Braga M, Tazzari S, (1995). Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp Neurol 133: 64-72.
14. Cayla C, Todiras M, Iliescu R, Saul VV, Gross V, Pilz B, et al,. (2007). Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. FASEB J 21: 1689-1698. (Pubitemid 46855614)
15. Chapman V, Dickenson AH, (1992). The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat. Eur J Pharmacol 219: 427-433.
16. Cliffer KD, Siuciak JA, Carson SR, Radley HE, Park JS, Lewis DR, et al,. (1998). Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat. Ann Neurol 43: 46-55. (Pubitemid 28124648)
17. 2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol 110: 193-198. (Pubitemid 23257778)
18. Costa R, Fernandes ES, Menezes-de-Lima O Jr, Campos MM, Calixto JB, (2006). Effect of novel selective non-peptide kinin B(1) receptor antagonists on mouse pleurisy induced by carrageenan. Peptides 27: 2967-2975. (Pubitemid 44584423)
19. 2 receptors in the scratching behaviour induced by proteinase-activated receptor-2 agonists in mice. Br J Pharmacol 159: 888-897.
20. Couture R, Harrisson M, Vianna RM, Cloutier F, (2001). Kinin receptors in pain and inflammation. Eur J Pharmacol 429: 161-176. (Pubitemid 33043994)
21. Dina OA, Chen X, Reichling D, Levine JD, (2001). Role of protein kinase Cepsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat. Neuroscience 108: 507-515. (Pubitemid 34037894)
22. Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR, (2004). Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109: 132-142. (Pubitemid 38479779)
23. Eckert A, Segond von Banchet G, Sopper S, Petersen M, (1999). Spatio-temporal pattern of induction of bradykinin receptors and inflammation in rat dorsal root ganglia after unilateral nerve ligation. Pain 83: 487-497.
24. 2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level. Neuropharmacology 43: 1188-1197. (Pubitemid 36013455)
25. Ferreira J, Campos MM, Pesquero JB, Araújo RC, Bader M, Calixto JB, (2002b). Evidence for the participation of kinins in Freund's adjuvant-induced inflammatory and nociceptive responses in kinin B1 and B2 receptor knockout mice. Neuropharmacology 41: 1006-1012.
26. 2 kinin receptor activation in mice. Br J Pharmacol 141: 787-794. (Pubitemid 38446179)
27. Ferreira J, Beirith A, Mori MAS, Araújo RC, Bader M, Pesquero JB, et al,. (2005). Reduced nerve injury-induced neuropathic pain in kinin B1 receptor knock-out mice. J Neurosci 25: 2405-2415.
28. Ferreira J, Trichês KM, Medeiros R, Cabrini DA, Mori MA, Pesquero JB, et al,. (2008). The role of kinin B1 receptors in the nociception produced by peripheral protein kinase C activation in mice. Neuropharmacology 54: 597-604.
29. 1 bradykinin receptors in inflammatory mechanical hyperalgesia. Pain 104: 683-691. (Pubitemid 37289068)
30. Gabra BH, Sirois P, (2002). Role of bradykinin B(1) receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice. Eur J Pharmacol 457: 115-124. (Pubitemid 35447653)
31. Gabra BH, Sirois P, (2003). Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice. Neuropeptides 37: 36-44. (Pubitemid 36384656)
32. Gordh T, Chu H, Sharma HS, (2006). Spinal nerve lesion alters blood-spinal cord barrier function and activates astrocytes in the rat. Pain 124: 211-221. (Pubitemid 44176215)
33. Hu P, McLachlan EM, (2002). Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience 112: 23-38. (Pubitemid 34603495)
34. Huang H, Player MR, (2010). Bradykinin B1 receptor antagonists as potential therapeutic agents for pain. J Med Chem 53: 5383-5389.
35. Hylden JL, Wilcox GL, (1980). Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67: 313-316. (Pubitemid 10007057)
36. Jensen TS, Baron R, (2003). Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 102: 1-8. (Pubitemid 36298856)
37. Lai J, Luo MC, Chen Q, Ma S, Gardell LR, Ossipov MH, et al,. (2006). Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nat Neurosci 9: 1534-1540. (Pubitemid 44862662)
38. Laursen SE, Belknap JK, (1986). Intracerebroventricular injections in mice: some methodological refinements. J Pharmacol Methods 16: 355-357. (Pubitemid 17189961)
39. Levy D, Zochodne DW, (2000). Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in na animal model of neuropathic pain. Pain 86: 265-271. (Pubitemid 30254267)
40. 1 receptors on primary sensory neurones that give rise to small calibre sciatic nerve fibres in rats. Neuroscience 107: 665-673.
41. Ma QP, Heavens R, (2000). Basal expression of bradykinin B(1) receptor in the spinal cord in humans and rats. Neuroreport 12: 2311-2314.
42. Marceau F, Regoli D, (2004). Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3: 845-852. (Pubitemid 39405945)
43. Menéndez L, Lastra A, Hidalgo A, Baamonde A, (2002). Unilateral hot plate test: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice. J Neurosci Methods 113: 91-97. (Pubitemid 33123334)
44. O'Connor AB, Dworkin RH, (2009). Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 122: S22-S32.
45. 1 receptors. Proc Natl Acad Sci U S A 97: 8140-8145. (Pubitemid 30460786)
46. Petcu M, Dias JP, Ongali B, Thibault G, Neugebauer W, Couture R, (2008). Role of kinin B1 and B2 receptors in a rat model of neuropathic pain. Int Immunopharmacol 8: 188-196.
47. Petersen M, Eckert AS, Segond von Banchet G, Heppelmann B, Klusch A, Kniffki KD, (1998). Plasticity in the expression of bradykinin binding sites in sensory neurons after mechanical nerve injury. Neuroscience 83: 949-959. (Pubitemid 28068913)
48. Polomano RC, Bennett GJ, (2001). Chemotherapy-evoked painful peripheral neuropathy. Pain Med 2: 8-14. (Pubitemid 32447626)
49. Polomano RC, Mannes AJ, Clark US, Bennett GJ, (2001). A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94: 293-230.
50. Quintão NL, Passos GF, Medeiros R, Paszcuk AF, Motta FL, Pesquero JB, et al,. (2008). Neuropathic pain-like behavior after brachial plexus avulsion in mice: the relevance of kinin B1 and B2 receptors. J Neurosci 28: 2856-2863. (Pubitemid 351398888)
51. Rashid MH, Inoue M, Matsumoto M, Ueda H, (2004). Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice. J Pharmacol Exp Ther 308: 1158-1164. (Pubitemid 38263993)
52. 2 receptor on nociception in rats and mice. Pain 71: 89-97. (Pubitemid 27245235)
53. 1 receptor in early diabetic pain neuropathy. J Neuroinflammation 7: 36.
54. Werner MF, Kassuya CA, Ferreira J, Zampronio AR, Calixto JB, Rae GA, (2007). Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats. Neuropharmacology 53: 48-57. (Pubitemid 47125942)
55. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C, (2008). Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44: 1507-1515.
56. Woolf CJ, Mannion RJ, (1999). Neuropathic pain: aetiology, symptons, mechanisms, and management. Lancet 353: 1959-1965.
57. Wothersponn G, Winter J, (2000). Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system. Neurosci Lett 294: 175-178.
58. Yamaguchi-Sase S, Hayashi I, Okamoto H, Nara Y, Matsuzaki S, Hoka S, et al,. (2003). Amelioration of hyperalgesia by kinin receptor antagonists or kininogen deficiency in chronic constriction nerve injury in rats. Inflamm Res 52: 164-169. (Pubitemid 36535265)